From invisible online markets, past border controls and straight to the consumer, fake pharmaceuticals are on the rise, but now a mix of anti-counterfeiting technology is helping halt the wave of fake drugs and their often lethal consequences.
Coalition for Epidemic Preparedness Innovation launched at the WEF Annual Meeting 2017
Launched today at the World Economic Forum (WEF) Annual Meeting in Davos was of the Coalition of Epidemic Preparedness Innovation (CEPI) – a global non-profit public-private partnership founded by the Government of Norway, the Government of India, the Bill & Melinda Gates Foundation, the Wellcome Trust and the WEF. The European Commission will contribute to CEPI's overall objectives in the area of epidemic preparedness, which are in line with that of the European Commission, and plans to co-fund actions with CEPI, such as through the Innovative Medicines Initiative.
- The Lancet
- The New England Journal of Medicine
- Wellcome Trust Press Release
- Watch: Let's #OutsmartEpidemics
European Medicines Agency – 2016 highlights for human medicines
EMA has published an overview of its key recommendations of 2016 in relation to the marketing authorisations of new medicines and the safety monitoring of authorised medicines.
EU launches personalised medicine projects to foster treatment of inflammatory disorders
EU-funded flagship projects, MultipleMS and SYSCID, receive EUR 15m each. These two projects focus on precision diagnostics and therapeutic targets in chronic inflammatory and autoimmune disorders as a major health care burden of industrialised societies. Chronic inflammatory diseases and autoimmunity constitute a group of incurable disorders of the immune system with a lifetime prevalence of over 10% in Europe.
Register for the 3rd IRDiRC Conference in Paris, France
The 3rd International Rare Diseases Research Consortium (IRDiRC) Conference, will be held on February 8-9, 2017, in Paris, France.
All stakeholders – investigators, policy makers, opinion leaders, critical thinkers, young researchers, patient advocates and industry members alike – active in the area of rare diseases from across the globe are invited to celebrate achievements in the field, identify future milestones and goals, and work toward bringing diagnoses and therapies to all rare disease patients.
Launch of a joint trans-national call for pathway analysis across neurodegenerative diseases
On 9 January 2017, the EU Joint Programme – Neurodegenerative Disease Research (JPND) has launched a joint trans-national call for pathway analysis across neurodegenerative diseases.
The €23 million call responds to a need of targeted investment to better understand the fundamental links between different diseases. It is made available to applicants from 20 countries.
Malaria, HIV vaccine achievable ‘in one or two decades’ – Dr Leonardo Santos Simão
We will see vaccines for malaria and HIV within the next one or two decades, predicts Dr Leonardo Santos Simão, the former health minister of Mozambique, who has been appointed High Representative South of the European & Developing Countries Clinical Trials Partnership (EDCTP), which aims to accelerate the development of new treatments, vaccines and diagnostic tools for diseases in sub-Saharan Africa.
Public stakeholder consultation
Interim evaluation of Joint Undertakings operating under Horizon 2020. All citizens and organisations are welcome to contribute to this consultation. Contributions are particularly sought from researchers, industry, entrepreneurs, innovators and all types of organisations that have participated in Horizon 2020 and in calls for proposals published by the Joint Undertakings in particular.
6-8 February 2017, Cambridge, United Kingdom - Immunogenomics of Disease: Accelerating to Patient Benefit
8-9 February 2017, Paris, France - 3rd IRDiRC Conference